PubMed:24737585
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-124 | Sentence | denotes | Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies. |
| TextSentencer_T2 | 125-249 | Sentence | denotes | Many studies have evaluated the association between cyclin D1 (CCND1) G870A polymorphism and cervical cancer susceptibility. |
| TextSentencer_T3 | 250-301 | Sentence | denotes | However, these studies showed inconsistent results. |
| TextSentencer_T4 | 302-384 | Sentence | denotes | The aim of this study was to derive a more precise estimation of this association. |
| TextSentencer_T5 | 385-615 | Sentence | denotes | We searched PubMed and Embase for related studies that had been published in English, and ten case-control studies with a total of 2,864 cases and 3,898 controls were finally identified to be eligible studies in the meta-analysis. |
| TextSentencer_T6 | 616-737 | Sentence | denotes | The association was assessed by summarizing the odds ratios (ORs) with the corresponding 95 % confidence intervals (CIs). |
| TextSentencer_T7 | 738-1166 | Sentence | denotes | Overall, there was no significant association between cyclin D1 (CCND1) G870A polymorphism and cervical cancer risk (for the allele model A vs. G: OR = 1.02, 95 % CI 0.88-1.19, p = 0.76; for the co-dominant model AA vs. GG: OR = 1.03, 95 % CI 0.75-1.41, p = 0.85; for the dominant model AA + GA vs. GG: OR = 1.00, 95 % CI 0.78-1.28, p = 0.99; for the recessive comparison AA vs. GA + GG: OR = 1.06, 95 % CI 0.85-1.32, p = 0.62). |
| TextSentencer_T8 | 1167-1268 | Sentence | denotes | In subgroup analysis by ethnicity, no significant difference was found in both Asians and Caucasians. |
| TextSentencer_T9 | 1269-1454 | Sentence | denotes | In summary, the present meta-analysis provides evidence that genotypes for the cyclin D1 (CCND1) G870A polymorphism may be not associated with genetic susceptibility of cervical cancer. |
| T1 | 0-124 | Sentence | denotes | Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: a meta-analysis based on ten case-control studies. |
| T2 | 125-249 | Sentence | denotes | Many studies have evaluated the association between cyclin D1 (CCND1) G870A polymorphism and cervical cancer susceptibility. |
| T3 | 250-301 | Sentence | denotes | However, these studies showed inconsistent results. |
| T4 | 302-384 | Sentence | denotes | The aim of this study was to derive a more precise estimation of this association. |
| T5 | 385-615 | Sentence | denotes | We searched PubMed and Embase for related studies that had been published in English, and ten case-control studies with a total of 2,864 cases and 3,898 controls were finally identified to be eligible studies in the meta-analysis. |
| T6 | 616-737 | Sentence | denotes | The association was assessed by summarizing the odds ratios (ORs) with the corresponding 95 % confidence intervals (CIs). |
| T7 | 738-1166 | Sentence | denotes | Overall, there was no significant association between cyclin D1 (CCND1) G870A polymorphism and cervical cancer risk (for the allele model A vs. G: OR = 1.02, 95 % CI 0.88-1.19, p = 0.76; for the co-dominant model AA vs. GG: OR = 1.03, 95 % CI 0.75-1.41, p = 0.85; for the dominant model AA + GA vs. GG: OR = 1.00, 95 % CI 0.78-1.28, p = 0.99; for the recessive comparison AA vs. GA + GG: OR = 1.06, 95 % CI 0.85-1.32, p = 0.62). |
| T8 | 1167-1268 | Sentence | denotes | In subgroup analysis by ethnicity, no significant difference was found in both Asians and Caucasians. |
| T9 | 1269-1454 | Sentence | denotes | In summary, the present meta-analysis provides evidence that genotypes for the cyclin D1 (CCND1) G870A polymorphism may be not associated with genetic susceptibility of cervical cancer. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1348-1357 | gene:595 | denotes | cyclin D1 |
| T1 | 1438-1453 | disease:C0007847 | denotes | cervical cancer |
| T2 | 1348-1357 | gene:595 | denotes | cyclin D1 |
| T3 | 1438-1453 | disease:C0302592 | denotes | cervical cancer |
| T4 | 1359-1364 | gene:595 | denotes | CCND1 |
| T5 | 1438-1453 | disease:C0007847 | denotes | cervical cancer |
| T6 | 1359-1364 | gene:595 | denotes | CCND1 |
| T7 | 1438-1453 | disease:C0302592 | denotes | cervical cancer |
| R1 | T0 | T1 | associated_with | cyclin D1,cervical cancer |
| R2 | T2 | T3 | associated_with | cyclin D1,cervical cancer |
| R3 | T4 | T5 | associated_with | CCND1,cervical cancer |
| R4 | T6 | T7 | associated_with | CCND1,cervical cancer |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 218-233 | HP_0030079 | denotes | cervical cancer |
| T2 | 227-233 | HP_0002664 | denotes | cancer |
| T3 | 833-848 | HP_0030079 | denotes | cervical cancer |
| T4 | 842-848 | HP_0002664 | denotes | cancer |
| T5 | 1438-1453 | HP_0030079 | denotes | cervical cancer |
| T6 | 1447-1453 | HP_0002664 | denotes | cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_24737585_0_0 | 0-9 | expanded | denotes | Cyclin D1 |
| SS2_24737585_0_0 | 11-16 | abbr | denotes | CCND1 |
| SS1_24737585_1_0 | 177-186 | expanded | denotes | cyclin D1 |
| SS2_24737585_1_0 | 188-193 | abbr | denotes | CCND1 |
| SS1_24737585_5_0 | 664-675 | expanded | denotes | odds ratios |
| SS2_24737585_5_0 | 677-680 | abbr | denotes | ORs |
| SS1_24737585_5_1 | 710-730 | expanded | denotes | confidence intervals |
| SS2_24737585_5_1 | 732-735 | abbr | denotes | CIs |
| SS1_24737585_6_0 | 792-801 | expanded | denotes | cyclin D1 |
| SS2_24737585_6_0 | 803-808 | abbr | denotes | CCND1 |
| SS1_24737585_8_0 | 1348-1357 | expanded | denotes | cyclin D1 |
| SS2_24737585_8_0 | 1359-1364 | abbr | denotes | CCND1 |
| AE1_24737585_0_0 | SS1_24737585_0_0 | SS2_24737585_0_0 | abbreviatedTo | Cyclin D1,CCND1 |
| AE1_24737585_1_0 | SS1_24737585_1_0 | SS2_24737585_1_0 | abbreviatedTo | cyclin D1,CCND1 |
| AE1_24737585_5_0 | SS1_24737585_5_0 | SS2_24737585_5_0 | abbreviatedTo | odds ratios,ORs |
| AE1_24737585_5_1 | SS1_24737585_5_1 | SS2_24737585_5_1 | abbreviatedTo | confidence intervals,CIs |
| AE1_24737585_6_0 | SS1_24737585_6_0 | SS2_24737585_6_0 | abbreviatedTo | cyclin D1,CCND1 |
| AE1_24737585_8_0 | SS1_24737585_8_0 | SS2_24737585_8_0 | abbreviatedTo | cyclin D1,CCND1 |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 24737585-0#0#9#gene595 | 0-9 | gene595 | denotes | Cyclin D1 |
| 24737585-0#11#16#gene595 | 11-16 | gene595 | denotes | CCND1 |
| 24737585-0#42#57#diseaseC0007847 | 42-57 | diseaseC0007847 | denotes | cervical cancer |
| 24737585-0#42#57#diseaseC0302592 | 42-57 | diseaseC0302592 | denotes | cervical cancer |
| 24737585-0#42#57#diseaseC4048328 | 42-57 | diseaseC4048328 | denotes | cervical cancer |
| 24737585-0#42#57#diseaseC0007847 | 42-57 | diseaseC0007847 | denotes | cervical cancer |
| 24737585-0#42#57#diseaseC0302592 | 42-57 | diseaseC0302592 | denotes | cervical cancer |
| 24737585-0#42#57#diseaseC4048328 | 42-57 | diseaseC4048328 | denotes | cervical cancer |
| 0#9#gene59542#57#diseaseC0007847 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC0007847 | associated_with | Cyclin D1,cervical cancer |
| 0#9#gene59542#57#diseaseC0302592 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC0302592 | associated_with | Cyclin D1,cervical cancer |
| 0#9#gene59542#57#diseaseC4048328 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC4048328 | associated_with | Cyclin D1,cervical cancer |
| 0#9#gene59542#57#diseaseC0007847 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC0007847 | associated_with | Cyclin D1,cervical cancer |
| 0#9#gene59542#57#diseaseC0302592 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC0302592 | associated_with | Cyclin D1,cervical cancer |
| 0#9#gene59542#57#diseaseC4048328 | 24737585-0#0#9#gene595 | 24737585-0#42#57#diseaseC4048328 | associated_with | Cyclin D1,cervical cancer |
| 11#16#gene59542#57#diseaseC0007847 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC0007847 | associated_with | CCND1,cervical cancer |
| 11#16#gene59542#57#diseaseC0302592 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC0302592 | associated_with | CCND1,cervical cancer |
| 11#16#gene59542#57#diseaseC4048328 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC4048328 | associated_with | CCND1,cervical cancer |
| 11#16#gene59542#57#diseaseC0007847 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC0007847 | associated_with | CCND1,cervical cancer |
| 11#16#gene59542#57#diseaseC0302592 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC0302592 | associated_with | CCND1,cervical cancer |
| 11#16#gene59542#57#diseaseC4048328 | 24737585-0#11#16#gene595 | 24737585-0#42#57#diseaseC4048328 | associated_with | CCND1,cervical cancer |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1292 | 0-9 | gene:595 | denotes | Cyclin D1 |
| T1293 | 42-57 | disease:C0007847 | denotes | cervical cancer |
| T1294 | 11-16 | gene:595 | denotes | CCND1 |
| R1 | T1292 | T1293 | associated_with | Cyclin D1,cervical cancer |
| R2 | T1292 | T1293 | associated_with | Cyclin D1,cervical cancer |
| R3 | T1292 | T1293 | associated_with | Cyclin D1,cervical cancer |
| R4 | T1294 | T1293 | associated_with | CCND1,cervical cancer |
| R5 | T1294 | T1293 | associated_with | CCND1,cervical cancer |
| R6 | T1294 | T1293 | associated_with | CCND1,cervical cancer |